Fact CheckerSign in

NCT02445885Completed

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
150 (estimated)
First submitted
8 May 2015
Start date
1 May 2015
Primary completion date
1 Sept 2025
Lead sponsor
Thomas Engstrom
NCT number
NCT02445885

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 1 May 2015 to the primary completion date, 1 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous Q-wave infarction in the current infarct related artery.
  • Previous Coronary Artery Bypass Surgery (CABG).

Other illness

  • Left main occlusion or multivessel disease which requires CABG.
  • Severe renal insufficiency.
  • Other severe illness with life expectancy less than 1 year

Other

  • Clinical instability which requires an acute invasive strategy.
  • Left Bundle Branch Block (LBBB).
  • Pacemaker
  • Chronic atrial fibrillation.
  • Pregnancy.

Who the study is looking for

  • Inclusion criteria:
  • Patients more than 18 years of age.
  • STEMI \> 12 hours and \< 36 hours.
  • Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP \> 90) and Killip class \< 3.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rigshospitalet
Coordinator of this site? Confirm its status
CopenhagenDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.